HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)
What is HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)?
HTLV-I associated myelopathy/tropical spastic paraparesis, or HAM/TSP, is a rare condition that affects the spinal cord. It develops in some people infected with the HTLV-I virus. This virus is a type of retrovirus that spreads through blood, sexual contact, or from mother to child during birth or breastfeeding.
The condition causes chronic inflammation in the spinal cord. This inflammation damages nerve fibers over time. Most people with HTLV-I infection never develop HAM/TSP. Only about 1 to 5 percent of infected people will get this neurological condition.
HAM/TSP usually progresses slowly over months or years. It mainly affects the ability to walk and control leg movements. The disease is most common in regions where HTLV-I infection rates are higher, including parts of Japan, the Caribbean, South America, and Africa.
Symptoms
- Weakness in the legs that gets worse over time
- Stiffness in the legs and difficulty walking
- Back pain and pain in the lower limbs
- Bladder problems, including urgency or difficulty urinating
- Constipation and bowel control issues
- Numbness or tingling in the feet and legs
- Loss of balance and coordination
- Sexual dysfunction
- Muscle spasms in the legs
Symptoms typically develop slowly and worsen over time. Some people may have very mild symptoms for years before the condition progresses. Early signs are often subtle and can be mistaken for other conditions.
Concerned about HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
HAM/TSP is caused by infection with the HTLV-I virus. The virus attacks cells in the immune system and nervous system. This triggers an inflammatory response in the spinal cord that damages nerve tissue. The exact reason why some infected people develop HAM/TSP while others do not remains unclear. Genetic factors and immune system differences may play a role.
Risk factors include being infected with HTLV-I through blood transfusion, unprotected sex with an infected partner, or breastfeeding from an infected mother. Women are more likely to develop HAM/TSP than men. The condition usually appears in adults between ages 40 and 50. Living in or traveling to regions with high HTLV-I infection rates increases exposure risk.
How it's diagnosed
Diagnosing HAM/TSP requires a combination of clinical examination, medical history, and specialized testing. Your doctor will assess your symptoms, check your reflexes, and evaluate muscle strength and coordination. Blood tests can detect HTLV-I antibodies or viral DNA, confirming infection. Spinal fluid analysis may show increased white blood cells and HTLV-I antibodies.
MRI scans of the spinal cord can reveal areas of inflammation or damage. Other conditions that cause similar symptoms must be ruled out, including multiple sclerosis and vitamin B12 deficiency. Talk to your doctor about specialized testing if you have symptoms or known HTLV-I infection. Early diagnosis helps with managing symptoms and planning treatment.
Treatment options
- Corticosteroids to reduce spinal cord inflammation during flare-ups
- Interferon alpha to help slow disease progression in some cases
- Physical therapy to maintain mobility and muscle strength
- Medications for bladder control problems, such as oxybutynin or tolterodine
- Muscle relaxants like baclofen or tizanidine for spasticity and stiffness
- Pain management with medications or nerve pain treatments
- Assistive devices such as canes, walkers, or wheelchairs as needed
- Occupational therapy to adapt daily activities
- Bladder training and bowel management programs
- Regular monitoring by a neurologist
Frequently asked questions
HTLV-I is the virus that can cause HAM/TSP, but most infected people never develop the condition. Having HTLV-I infection means the virus is in your body. HAM/TSP only develops when the virus triggers chronic spinal cord inflammation. Only 1 to 5 percent of people with HTLV-I will get HAM/TSP.
Both conditions affect the spinal cord and cause similar symptoms like leg weakness and bladder problems. HAM/TSP is caused by a viral infection, while MS is an autoimmune disease. HAM/TSP typically progresses more slowly and mainly affects the legs. Testing for HTLV-I antibodies and viral DNA helps distinguish between the two conditions.
There is currently no cure for HAM/TSP. Treatment focuses on managing symptoms and slowing disease progression. Some medications like corticosteroids and interferon can help reduce inflammation and may slow the condition. Physical therapy and supportive care can maintain quality of life and independence for many years.
HAM/TSP usually progresses slowly over months to years. The rate varies greatly between individuals. Some people experience gradual worsening over decades, while others may have a faster progression. Early treatment and regular medical care may help slow the disease in some cases.
HAM/TSP itself is not contagious, but the HTLV-I virus that causes it can spread to others. The virus spreads through blood, sexual contact, or from mother to child during pregnancy or breastfeeding. People with HTLV-I should take precautions to avoid transmitting the virus to others.
There is no proven way to prevent HAM/TSP in people already infected with HTLV-I. Regular medical monitoring can help detect early signs of the condition. Maintaining overall health through good nutrition, exercise, and avoiding other infections may support immune function. Research is ongoing to find prevention strategies.
Blood tests can detect HTLV-I antibodies, which show if you have been infected with the virus. More specific tests can detect HTLV-I DNA in the blood. If initial antibody tests are positive, confirmatory testing is usually done to rule out false positives. Your doctor may also measure viral load to assess infection activity.
Testing is recommended if you have symptoms of HAM/TSP or unexplained neurological problems. You should also consider testing if you lived in or received blood transfusions in high-risk areas. People with sexual partners who have HTLV-I or children of infected mothers should discuss testing with their doctor.
Regular physical therapy helps maintain muscle strength and mobility. Staying active within your abilities can slow functional decline. Good bladder and bowel habits prevent complications. Eating a balanced diet supports overall health and healing. Avoiding falls through home safety modifications protects against injury.
Not everyone with HAM/TSP will need a wheelchair. The disease affects people differently and progresses at varying rates. Many people manage with canes or walkers for years. A wheelchair may eventually help conserve energy and maintain independence. Physical therapy and early treatment can help preserve walking ability longer.